Irshad and colleagues reported that the expression of p16 occurs in 52.3% of HL cases and Zhao demonstrated the expression of the p16 protein in 71.7% of HL cases, which is more compared with our study [48,49]. This evidence concerns the gene CDKN2A and Hodgkins lymphoma.